Your browser doesn't support javascript.
loading
Targeting PDZ-binding kinase is anti-tumorigenic in novel preclinical models of ACC.
Kar, Adwitiya; Zhang, Yu; Yacob, Betelehem W; Saeed, Jordan; Tompkins, Kenneth D; Bagby, Stacey M; Pitts, Todd M; Somerset, Hilary; Leong, Stephen; Wierman, Margaret E; Kiseljak-Vassiliades, Katja.
Afiliação
  • Kar A; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Zhang Y; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Yacob BW; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Saeed J; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Tompkins KD; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Bagby SM; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Pitts TM; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Somerset H; Department of Pathology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Leong S; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Wierman ME; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Kiseljak-Vassiliades K; Research Service, Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado, USA.
Endocr Relat Cancer ; 26(10): 765-778, 2019 10.
Article em En | MEDLINE | ID: mdl-31325906
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Adrenocortical / Quinases de Proteína Quinase Ativadas por Mitógeno / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Endocr Relat Cancer Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Adrenocortical / Quinases de Proteína Quinase Ativadas por Mitógeno / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Endocr Relat Cancer Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos